Individual projects requesting up to $50,000 USD will be considered. The total budget for this RFP is $ 250,000 USD. Maximum project length is 12 months. - Tuesday, April 28, 2026
Pfizer
This RFP invites research proposals aimed at assessing clinical outcomes associated with the use of Aztreonam- Avibactam (ATM-AVI) in real world clinical settings.
This initiative supports early Phase 2 clinical trials evaluating mTOR inhibitors' efficacy in treating cutaneous sarcoidosis, aiming to advance understanding of immunopathology in this rare disease and lay the groundwork for subsequent Phase 2b/3 or Phase 3 trials.
The mission of the APMRF is to promote research that furthers understanding of the molecular basis of Niemann Pick Type C disease and targets development of novel strategies to treat and/or cure the disease.
Maximum Budget (USD): $125,000 per year for 1 or 2 years - Sunday, February 15, 2026(Letter of Intent); Wednsday, April 15, 2026 (Application)
Friedreich's Ataxia Research Alliance (FARA)
The Keith Michael Andrus Cardiac Research Award aims to advance the understanding and treatment of cardiomyopathy associated with FA. Proposals for this award should focus on advancing understanding and/or treatment of the cardiac involvement in FA.
Maximum Budget (USD): $200,000 per year for 1 or 2 years - Sunday, February 15, 2026(Letter of Intent); Wednsday, April 15, 2026 (Application)
Friedreich's Ataxia Research Alliance (FARA)
The Kyle Bryant Translational Research Award honors its namesake for his diligent efforts to aid the rapid translation of basic research discoveries into clinical applications.
Kindly refer to the link before for information on the budget of each preclinical grant. - Friday, October 24, 2025(Letter of Intent);Wednesday, April 15,2026 (Full Proposal)
Osteosarcoma Institute, US
The aim of the preclinical grants is to support innovative research that advances understanding of osteosarcoma biology, accelerate the development of new therapies, and ultimately improve patient survival and quality of life.
The budget should be justified by the activities to be carried out and aligned with Unitaid’s strategic objectives. - April 9, 2026
Unitaid save life faster
This Call for Proposals seeks to accelerate access to cervical cancer prevention and treatment services, with a particular focus on secondary prevention.
Maximum of 1.0 M€. Funding is granted for a maximum of four years. - Wednesday, 08 April,(pre-proposal)
Lymph & Co Foundation
The aim of this call is to fund groundbraking translational research on malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders)
Up to £300,000 - April 7, 2026; Q&A session 1: Monday 23 February, 4pm (GMT); Q&A session 2: Thursday 26 March, 11am (GMT)
Cure Parkinson's, GB
The objective of this funding call is to accelerate the additional research required for therapeutic candidates to move forward into clinical studies. Applications investigating secukinumab in an alpha synuclein model of Parkinson’s are welcomed.
Pfizer
Milken Institute
Ara Parseghian Medical Research Fund (APMRF)
Friedreich's Ataxia Research Alliance (FARA)
Osteosarcoma Institute, US
Unitaid save life faster
Lymph & Co Foundation
Wellcome Trust
Cure Parkinson's, GB
Worldwide Cancer Research
